PodcastIntel
Sign in Get Started Free
HCPLive
HCPLive

Mepolizumab Cuts COPD Exacerbations Across Smoking Status: Claus Vogelmeier, MD

Sep 24, 2026 · 0:03:07
Listen to Episode
✨ AI Summary
  • Mepolizumab reduced COPD exacerbations in smokers and former smokers.
  • Benefit on serious outcomes appeared limited to former smokers.
  • Analysis from METREX, METREO, and MATINEE trials presented.

Guests on This Episode

CV
Claus Vogelmeier
German internist and pneumologist · 1 podcast appearance
›

More from HCPLive

HCPLive
Subcutaneous Furosemide Bioequivalent to IV, Bioavailable Across Multiple Injection Sites
Oct 12, 2026 · 0:03:18
HCPLive
Targeting Senescent Cells in Actinic Keratosis With RLS-1496
Oct 12, 2026 · 0:04:25
HCPLive
Atopic Dermatitis Biologic Selection, With Raj Chovatiya, MD, PhD
Oct 12, 2026 · 0:03:33
HCPLive
Tovinontrine 50 mg Improves cGMP With Minimal Effect on NT-proBNP in HFpEF
Oct 12, 2026 · 0:06:00
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to HCPLive and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →